Repligen
$181.70Change from previous close: +2.52%Absolute change: +$4.47
At a glance
- Revenue growth
- +16.36%
- 2025 vs 2024
- Net margin
- 6.6%
- 2024: -4.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | 738 | 634 | 632 | 802 |
| Cost of revenue | 352 | 360 | 354 | 346 |
| Gross profit | 386 | 275 | 278 | 456 |
| Selling, general and administrative | 291 | 263 | 219 | 216 |
| Research and development | 54.2 | 43.2 | 42.7 | 43.9 |
| Operating income | 41.6 | -31.9 | 17.1 | 196 |
| EBIT | 83.9 | -6.3 | 59.2 | 220 |
| EBITDA | 181 | 80.3 | 145 | 277 |
| Interest expense | 21.5 | 20.7 | 2.5 | 1.2 |
| Pre-tax income | 62.4 | -27.0 | 56.7 | 219 |
| Income tax | 13.5 | -1.5 | 21.1 | 33.2 |
| Net income | 48.9 | -25.5 | 35.6 | 186 |
| Net income to common shareholders | 48.9 | -25.5 | 35.6 | 186 |
| Basic EPS | 0.87 | -0.46 | 0.75 | 3.35 |
| Diluted EPS | 0.86 | -0.46 | 0.74 | 3.24 |
| Average shares (basic) | 56.2 | 55.9 | 55.7 | 55.5 |
| Average shares (diluted) | 56.6 | 55.9 | 56.4 | 57.5 |